Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genetic SignaturesASX:GSS -1.49% Median PS Value is A$1.09 as of Jul. 21, 2026, which is 100% below its 10-year median of 0.33. The stock has 4 warning signs investors should review. Among 88 Medical Diagnostics & Research companies, Genetic Signatures ranks better than 96.59% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Genetic Signatures's Median PS Value or its related term are showing as below:
ASX:GSS'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.06 Med: 0.33 Max: 0.33
Current: 0.06
During the past 11 years, the highest Price to Median PS Value of Genetic Signatures was 0.33. The lowest was 0.06. And the median was 0.33.
ASX:GSS's Price-to-Median-PS-Value is ranked better than 96.59% of 88
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.89
vs ASX:GSS: 0.06
Genetic Signatures (ASX:GSS) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Genetic Signatures's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.066
/
1.09
=
0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetic Signatures Median PS Value Related Terms
Genetic Signatures Median PS Value Historical Data
* Premium members only.
The historical data trend for Genetic Signatures's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:GSS vs TMO, DHR, IDXX: Median PS Value Comparison
For the Diagnostics & Research subindustry, Genetic Signatures's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genetic Signatures Price-to-Median-PS-Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Genetic Signatures's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 15.5714.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Genetic Signatures's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.07.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genetic Signatures (ASX:GSS) has a Median PS Value of A$1.09 as of Jul. 21, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Genetic Signatures and its competitors. This is 230% above median its historical median of 0.33. Over the past decade, Genetic Signatures' Median PS Value has ranged from 0.06 to 0.33. According to the industry distribution chart, Genetic Signatures ranks #3 out of 88 companies in the Medical Diagnostics & Research industry, placing it in the top 3.4%.
Is Genetic Signatures' Median PS Value too high?
Genetic Signatures' current Median PS Value of A$1.09 is 230% above median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 0.33. Based on the distribution chart, Genetic Signatures ranks #3 out of 88 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Genetic Signatures' Median PS Value compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Genetic Signatures ranks #3 out of 88 companies for Median PS Value. This places Genetic Signatures in the top 3% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.89. Historically, Genetic Signatures' own Median PS Value has ranged from 0.06 to 0.33 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Diagnostics & Research company?
The median Median PS Value among Medical Diagnostics & Research companies is 0.89, based on 88 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Genetic Signatures and its competitors. For the Medical Diagnostics & Research industry, the median Median PS Value is 0.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genetic Signatures's current Median PS Value is A$1.09, which is 230% above median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genetic Signatures stock overvalued right now?
Based on GuruFocus' analysis, Genetic Signatures (ASX:GSS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.38, compared to a current price of A$0.07 — trading 82.6% below its estimated fair value. The current Median PS Value is A$1.09, which is 230% above median its 10-year median of 0.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Genetic Signatures (ASX:GSS), the current Median PS Value is A$1.09 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genetic Signatures Ltd is a specialist molecular diagnostics company, specializing in syndromic multiplex real-time PCR testing. The company offers products for the routine detection of infectious diseases and pathogens. It has three operating segments based on regions: Asia Pacific, EMEA, and Americas. It generates the majority of its revenue from the Asia Pacific region. The group's operations are based in Australia, with sales and support teams in the UK, Germany, and the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:GSS has been successfully added to your 
